IL125523A0 - Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) - Google Patents

Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)

Info

Publication number
IL125523A0
IL125523A0 IL12552397A IL12552397A IL125523A0 IL 125523 A0 IL125523 A0 IL 125523A0 IL 12552397 A IL12552397 A IL 12552397A IL 12552397 A IL12552397 A IL 12552397A IL 125523 A0 IL125523 A0 IL 125523A0
Authority
IL
Israel
Prior art keywords
methods
desmoid tumors
inhibiting
fibromatoses
musculoaponeurotic fibromatoses
Prior art date
Application number
IL12552397A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603148.9A external-priority patent/GB9603148D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL125523A0 publication Critical patent/IL125523A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
IL12552397A 1996-01-29 1997-01-27 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) IL125523A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1077396P 1996-01-29 1996-01-29
GBGB9603148.9A GB9603148D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
PCT/US1997/002287 WO1997026878A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)

Publications (1)

Publication Number Publication Date
IL125523A0 true IL125523A0 (en) 1999-03-12

Family

ID=26308707

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12552397A IL125523A0 (en) 1996-01-29 1997-01-27 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)

Country Status (11)

Country Link
EP (1) EP0907361A4 (en)
JP (1) JP2000503995A (en)
KR (1) KR19990082055A (en)
CN (1) CN1209746A (en)
AU (1) AU707675B2 (en)
CZ (1) CZ235398A3 (en)
EA (1) EA199800678A1 (en)
IL (1) IL125523A0 (en)
NO (1) NO983452D0 (en)
PL (1) PL328127A1 (en)
WO (1) WO1997026878A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2135195C1 (en) * 1998-12-17 1999-08-27 Овсюк Валерий Григорьевич Method for producing material containing prostate cells and treating the cases of uterine fibromatosis, chronic prostatitis and male sexual function disorders by applying transplantation method
AU781168B2 (en) * 2001-01-26 2005-05-12 Pfizer Products Inc. Method of treating certain cancers using an estrogen agonist/antagonist

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
US5457116A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods of inhibiting uterine fibrosis
JPH07149638A (en) * 1993-10-15 1995-06-13 Eli Lilly & Co Method for medical treatment of resistant neoplasm
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
NO983452L (en) 1998-07-27
EP0907361A4 (en) 2002-05-02
PL328127A1 (en) 1999-01-18
CZ235398A3 (en) 1999-02-17
EA199800678A1 (en) 1999-02-25
WO1997026878A1 (en) 1997-07-31
EP0907361A1 (en) 1999-04-14
KR19990082055A (en) 1999-11-15
JP2000503995A (en) 2000-04-04
AU2124097A (en) 1997-08-20
CN1209746A (en) 1999-03-03
AU707675B2 (en) 1999-07-15
NO983452D0 (en) 1998-07-27

Similar Documents

Publication Publication Date Title
ZA977087B (en) Methods of cancer treatment using naaladase inhibitors
HUP9700602A3 (en) New inhibitors of bone-resorption and vitronectine-receptor-antagonists
ZA977085B (en) Naaladase inhibitors
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
PL327569A1 (en) Promedications of thrombosin inhibitors
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
PL328831A1 (en) Combined treatment of osteoporosis
PL331920A1 (en) Spirocyclic inhibitors of metaloproteases
IL112043A0 (en) Methods of inhibiting emperfect tissue repair
PL331803A1 (en) Bidonoric metaloprotease inhibitors
IL127605A0 (en) Methods of cancer treatment using naaladase inhibitors
EP1017459A4 (en) Game of chance
GB9621570D0 (en) Formulations and methods for inhibiting bone loss
PL331766A1 (en) Method of inhibiting fas expression
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
ZA9711238B (en) Preparation of N-substituted 3-hydroxypyrozoles
ZA9710989B (en) Polyprolyl inhibitors of cyclophilin
CY2590B2 (en) Preparation of 1-butyl-4-piperidinylmethylamine
IL125523A0 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
GB9603148D0 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
IL115383A0 (en) Methods of inhibiting endometrial mitoses
GB9617346D0 (en) Therapeutic methods and compositions for use therein
HUP9901961A3 (en) Use of benzotiophene derivatives for producing pharmaceuticals inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides